An Act protecting patient safety regarding non-FDA approved drugs
Massachusetts bill establishes state-level patient safety regulations for prescribing and dispensing non-FDA approved drugs to protect patients from potential harms.
Massachusetts bill establishes state-level patient safety regulations for prescribing and dispensing non-FDA approved drugs to protect patients from potential harms.
S 1497 establishes patient safety protections regarding the use of non-FDA approved drugs in Massachusetts. The bill creates regulatory requirements and oversight mechanisms for prescribing, dispensing, and monitoring non-FDA approved medications to ensure patient safety standards are maintained.
Non-FDA approved drugs—including compounded medications, drugs approved in other countries but not the U.S., and experimental treatments—exist in a regulatory gray area that can pose safety risks if used without proper safeguards. This bill addresses a real gap in patient protection by establishing state-level oversight for drugs that fall outside federal FDA approval frameworks, which is particularly relevant for vulnerable patients seeking alternative treatments.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.